Life Science Analytics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
The Global Life Science Analytics Market Size accounted for USD 27.3 Billion in 2022 and is projected to achieve a market size of USD 80.6 Billion by 2032 growing at a CAGR of 11.5% from 2023 to 2032.
Life Science Analytics Market Key Highlights
- Global life science analytics market revenue is expected to increase by USD 80.6 Billion by 2032, with a 11.5% CAGR from 2023 to 2032
- North America region led with more than 49% of life science analytics market share in 2022
- According to a report by McKinsey & Company, the use of advanced analytics in clinical trials could lead to a 30% reduction in development costs and a 50% reduction in trial times
- The U.S. Food and Drug Administration (FDA) reports that the use of advanced analytics in drug development can reduce the time and cost of bringing a new drug to market by up to 50%
- By component, the service segment has held a revenue share of 57% in 2022
- By end-user, Pharmaceutical & Biotechnology Companies segment has accounted for a revenue share of around 45% in 2022
- Growing demand for personalized medicine and targeted therapies, drives the life science analytics market value
Life Science Analytics is the process of gathering, analyzing, and interpreting data related to the life science industry, including pharmaceuticals, biotechnology, medical devices, and healthcare. It involves the use of data and analytics tools to gain insights and make informed decisions that improve patient outcomes, streamline operations, and optimize resources. Life science analytics can help pharmaceutical companies to identify new drug targets, optimize clinical trials, and manage regulatory compliance, while healthcare providers can use it to improve patient care, reduce costs and enhance the patient experience.
The global Life Science Analytics market has been growing at a rapid pace in recent years, driven by a growing demand for better healthcare services, increasing adoption of analytics solutions by pharmaceutical companies and healthcare providers, and the emergence of new technologies such as big data and artificial intelligence. Moreover, the growth is expected to be driven by the increasing adoption of advanced analytics tools, rising demand for personalized medicine, and the need for real-time data analysis in healthcare. The North American region is expected to dominate the market due to the presence of several key players and a high adoption rate of advanced analytics tools in the healthcare sector.
Global Life Science Analytics Market Trends
Market Drivers
- Growing demand for personalized medicine and targeted therapies
- Increasing need for real-time data analysis in the healthcare industry
- Adoption of advanced analytics tools by pharmaceutical companies and healthcare providers
- Technological advancements such as big data analytics and artificial intelligence
- Rising pressure to reduce healthcare costs and improve patient outcomes
Market Restraints
- Lack of skilled professionals in the life science analytics industry
- High implementation costs and data security concerns
Market Opportunities
- Integration of analytics tools with electronic health records (EHRs) and other healthcare systems
- Expansion of analytics applications to areas such as genomics and precision medicine
Life Science Analytics Market Report Coverage
| Market | Life Science Analytics Market |
| Life Science Analytics Market Size 2022 | USD 27.3 Billion |
| Life Science Analytics Market Forecast 2032 | USD 80.6 Billion |
| Life Science Analytics Market CAGR During 2023 - 2032 | 11.5% |
| Life Science Analytics Market Analysis Period | 2020 - 2032 |
| Life Science Analytics Market Base Year | 2022 |
| Life Science Analytics Market Forecast Data | 2023 - 2032 |
| Segments Covered | By Type, By Component Type, By Delivery Model, By Application, By End Users, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | IQVIA Holdings Inc., SAS Institute Inc., Accenture, Cognizant, Wipro Limited, IBM Corporation, MaxisIT Inc., Take Solutions Limited, Sciformix Corporation, Optum, Inc., Oracle Corporation, and Trinity Pharma Solutions. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Life science analytics helps healthcare organizations to overcome challenges such as being more cost-efficient, and patient-centric and improving the services or products. Life science analytics also helps to derive decisions on product positioning and planning. The market for life science analytics is expected to grow due to increasing demand for standardization of data, availability of big data in the life science industry, and greater application of analytical solutions in the healthcare industry.
The market for life science analytics is expected to grow significantly during the forecast period. Government initiatives to develop and deploy healthcare IT globally are the principal drivers for market growth. For instance, in the 58th World Health Assembly, the World Health Organization (WHO) urged member states to follow a few strategic actions to promote healthcare IT. One of them was to develop a long-term action plan for the deployment of healthcare IT services in various areas of healthcare and to develop the infrastructure for information and communication technologies with universal access. Another one was to establish and implement a national electronic public health information system, which would improve the capacity of surveillance and get rapid response to disease and public health emergencies. However, data privacy issues, financial restrictions, and a lack of skilled professionals are a few factors, which might obstruct the growth of the market in the long run.
Life Science Analytics Market Segmentation
The global life science analytics market segmentation is based on type, component type, delivery model, application, end users, and geography.
Life Science Analytics Market By Type
- Descriptive Analytics
- Prescriptive Analytics
- Predictive Analytics
- Discovery Analytics
- Diagnostic Analytics
According to the life science analytics industry analysis, the descriptive analytics segment held the largest market share in 2022. Descriptive analytics provides insights into past performance, enabling companies to identify areas for improvement and make data-driven decisions. The demand for descriptive analytics in the life science industry is driven by the need to improve patient outcomes, optimize operations, and reduce costs. The growing availability of data from various sources such as clinical trials, electronic health records, and wearables is also driving the growth of the descriptive analytics segment. Moreover, the segment is expected to continue to dominate the market during the forecast period, driven by the increasing adoption of analytics tools in pharmaceutical companies and healthcare providers.
Life Science Analytics Market By Component Type
- Software
- Services
In terms of component type, the services segment is dominating the market in 2022. This growth is due to the increasing demand for specialized services such as data management, data integration, and data quality services in the life science industry. Services include consulting, implementation, and maintenance of analytics solutions, as well as training and support services for end-users. The demand for services is driven by the need for specialized expertise in data analytics, as well as the need for customized solutions that meet the specific needs of pharmaceutical companies and healthcare providers.
Life Science Analytics Market By Delivery Model
- On-demand model
- On-premise model
According to the life science analytics market forecast, the on-demand model segment is expected to witness significant growth in the coming years. The on-demand model refers to the delivery of analytics solutions through a cloud-based platform, allowing users to access data and analytics tools on an as-needed basis. The on-demand model offers several advantages over traditional on-premise solutions, including scalability, flexibility, and cost-effectiveness. The demand for on-demand analytics solutions in the life science industry is driven by the need for real-time data analysis, as well as the growing availability of data from various sources such as wearables, social media, and electronic health records. The on-demand model also allows pharmaceutical companies and healthcare providers to access analytics tools without the need for large upfront investments in hardware and software.
Life Science Analytics Market By Application
- Research & Development
- Clinical Trials
- Preclinical Trials
- Sales & Marketing
- Supply Chain Optimization
- Regulatory Compliance
- Pharmacovigilance
Based on the application, the clinical trials segment is expected to witness significant growth in the coming years. Clinical trials are an essential part of drug development and require the analysis of large amounts of data from various sources, including patient data, lab results, and medical imaging. Analytics solutions are increasingly being used to optimize clinical trial design, monitor patient safety, and analyze trial data to identify potential drug candidates. The demand for analytics solutions in the clinical trials segment is driven by the need to accelerate drug development timelines, reduce costs, and improve patient outcomes. The use of analytics in clinical trials can help pharmaceutical companies and clinical research organizations (CROs) make data-driven decisions, identify potential issues early in the trial, and optimize the trial design to improve the chances of success.
Life Science Analytics Market By End Users
- Pharmaceutical & Biotechnology Companies
- Research Centers
- Medical Device Companies
- Third-party Administrators
In terms of end users, the pharmaceutical & biotechnology companies segment has been experiencing significant growth in recent years. Analytics solutions are increasingly being used by pharmaceutical and biotech companies to accelerate drug development, optimize clinical trial design, and improve manufacturing processes. Analytics can also be used to identify new drug targets and optimize drug dosing, helping to improve patient outcomes. The demand for analytics solutions in the pharmaceutical and biotechnology companies segment is driven by the need to reduce drug development timelines, improve drug efficacy, and reduce costs. Analytics solutions can help pharmaceutical and biotech companies make data-driven decisions, identify potential issues early in the drug development process, and optimize drug development processes to improve the chances of success. Moreover, the increasing adoption of artificial intelligence (AI) and machine learning (ML) in the life science industry is driving the demand for analytics solutions in the pharmaceutical and biotechnology companies segment.
Life Science Analytics Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Life Science Analytics Market Regional Analysis
North America is dominating the life science analytics market due to several factors, including a large number of pharmaceutical and biotech companies, a highly developed healthcare infrastructure, and strong government support for research and development. The region has a high level of investment in the life sciences, which has led to the development of a mature market for life science analytics solutions. One of the key reasons for North America's dominance in the life science analytics market is the presence of several large pharmaceutical and biotech companies in the region. These companies are major consumers of analytics solutions for drug development and clinical trials, and their demand for these solutions has helped to drive the life science analytics market growth in the region. Another factor contributing to North America's dominance in the life science analytics market is the highly developed healthcare infrastructure in the region.
Life Science Analytics Market Player
Some of the top life science analytics market companies offered in the professional report include IQVIA Holdings Inc., SAS Institute Inc., Accenture, Cognizant, Wipro Limited, IBM Corporation, MaxisIT Inc., Take Solutions Limited, Sciformix Corporation, Optum, Inc., Oracle Corporation, and Trinity Pharma Solutions.
Frequently Asked Questions
What was the market size of the global life science analytics in 2022?
The market size of life science analytics was USD 27.3 Billion in 2022.
What is the CAGR of the global life science analytics market from 2023 to 2032?
The CAGR of life science analytics is 11.5% during the analysis period of 2023 to 2032.
Which are the key players in the life science analytics market?
The key players operating in the global market are including IQVIA Holdings Inc., SAS Institute Inc., Accenture, Cognizant, Wipro Limited, IBM Corporation, MaxisIT Inc., Take Solutions Limited, Sciformix Corporation, Optum, Inc., Oracle Corporation, and Trinity Pharma Solutions.
Which region dominated the global life science analytics market share?
North America held the dominating position in life science analytics industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of life science analytics during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global life science analytics industry?
The current trends and dynamics in the life science analytics industry include growing demand for personalized medicine and targeted therapies, and increasing need for real-time data analysis in the healthcare industry.
Which type held the maximum share in 2022?
The descriptive analytics type held the maximum share of the life science analytics industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
